Allspring Global Investments Holdings LLC Sells 4,563 Shares of Globe Life Inc. $GL

Allspring Global Investments Holdings LLC cut its stake in shares of Globe Life Inc. (NYSE:GL) by 33.8% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 8,929 shares of the company’s stock after selling 4,563 shares during the period. Allspring Global Investments Holdings LLC’s holdings in Globe Life were worth $1,254,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of the company. Hilton Head Capital Partners LLC acquired a new position in shares of Globe Life in the fourth quarter valued at approximately $30,000. CYBER HORNET ETFs LLC acquired a new stake in Globe Life during the 2nd quarter worth approximately $28,000. MUFG Securities EMEA plc acquired a new stake in Globe Life during the 2nd quarter worth approximately $31,000. Torren Management LLC bought a new stake in Globe Life during the 4th quarter worth approximately $37,000. Finally, AdvisorNet Financial Inc grew its holdings in Globe Life by 41.1% during the 1st quarter. AdvisorNet Financial Inc now owns 316 shares of the company’s stock worth $44,000 after acquiring an additional 92 shares during the last quarter. 81.61% of the stock is currently owned by institutional investors.

Key Headlines Impacting Globe Life

Here are the key news stories impacting Globe Life this week:

• Positive Sentiment: Keefe, Bruyette & Woods trimmed its price target only modestly to $190 from $192 and kept an outperform rating, implying roughly 9% upside from recent levels. Benzinga article
• Positive Sentiment: TD Cowen also reiterated a bullish view, forecasting strong price appreciation for Globe Life (GL). American Banking News article
• Positive Sentiment: Management raised its 2026 net operating EPS guidance to $15.55-$15.95 and lifted share repurchases to $670 million-$700 million, signaling confidence in future earnings and capital returns. Seeking Alpha article
• Neutral Sentiment: Globe Life’s Q2 revenue came in roughly in line with expectations, and underwriting income remained strong, showing the core business is still performing acceptably despite some headwinds. Reuters article
• Negative Sentiment: Q2 earnings of $3.61 per share missed the consensus estimate of $3.67, and several reports pointed to softer sales and rising expenses as reasons for investor concern. MSN article

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on GL shares. Truist Financial raised their price target on shares of Globe Life from $180.00 to $185.00 and gave the company a “buy” rating in a research note on Friday, April 24th. JPMorgan Chase & Co. boosted their price objective on shares of Globe Life from $181.00 to $201.00 and gave the stock an “overweight” rating in a research note on Tuesday, July 21st. TD Cowen increased their price objective on Globe Life from $215.00 to $225.00 and gave the company a “buy” rating in a report on Wednesday, July 22nd. Morgan Stanley raised their target price on Globe Life from $181.00 to $208.00 and gave the stock an “overweight” rating in a research report on Monday, July 6th. Finally, Weiss Ratings downgraded Globe Life from a “buy (b)” rating to a “buy (b-)” rating in a report on Monday, July 20th. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and three have given a Hold rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $187.40.

Globe Life Stock Performance

Shares of Globe Life stock opened at $173.64 on Monday. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.38. The business has a 50-day moving average price of $169.07 and a two-hundred day moving average price of $152.99. Globe Life Inc. has a 1-year low of $127.85 and a 1-year high of $191.55. The company has a market cap of $13.48 billion, a P/E ratio of 11.53 and a beta of 0.47.

Globe Life (NYSE:GL) last posted its quarterly earnings data on Wednesday, July 22nd. The company reported $3.61 earnings per share for the quarter, missing the consensus estimate of $3.67 by ($0.06). The business had revenue of $1.60 billion during the quarter, compared to the consensus estimate of $1.59 billion. Globe Life had a return on equity of 20.73% and a net margin of 19.58%.The business’s revenue was up 8.0% on a year-over-year basis. During the same period last year, the business posted $3.05 earnings per share. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. As a group, analysts anticipate that Globe Life Inc. will post 15.7 EPS for the current year.

Globe Life Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Monday, July 6th will be given a dividend of $0.33 per share. The ex-dividend date of this dividend is Monday, July 6th. This represents a $1.32 annualized dividend and a dividend yield of 0.8%. Globe Life’s dividend payout ratio (DPR) is 8.76%.

Insider Activity at Globe Life

In other news, CEO James Matthew Darden sold 4,663 shares of Globe Life stock in a transaction on Tuesday, April 28th. The shares were sold at an average price of $153.88, for a total value of $717,542.44. Following the completion of the sale, the chief executive officer owned 58,451 shares in the company, valued at $8,994,439.88. The trade was a 7.39% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Cheryl Alston sold 8,258 shares of the stock in a transaction on Thursday, June 25th. The stock was sold at an average price of $179.24, for a total transaction of $1,480,163.92. Following the transaction, the director directly owned 16,621 shares in the company, valued at approximately $2,979,148.04. This represents a 33.19% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders sold 90,187 shares of company stock worth $14,299,874. Corporate insiders own 2.11% of the company’s stock.

Globe Life Company Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.